Sodium-glucose transport-2 (SGLT-2) inhibitors

DRUG2 trials

Sponsors

Sanofi, University of Aberdeen

Conditions

Breast CancerType 2 Diabetes Mellitus

Phase 4

A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

CompletedNCT02954692

SanofiType 2 Diabetes Mellitus

Start: 2016-11-30End: 2017-12-22Updated: 2019-01-14

Unknown Phase

Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

RecruitingNCT07070765

University of AberdeenBreast Cancer

Start: 2025-12-12End: 2028-10-31Target: 70Updated: 2026-04-30